The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Lilly(Eli) & Co (NYSE: LLY) closed at $703.21 in the last session, up 0.74% from day before closing price of $698.05. In other words, the price has increased by $0.74 from its previous closing price. On the day, 5.93 million shares were traded. LLY stock price reached its highest trading level at $714.26 during the session, while it also had its lowest trading level at $698.55.
Ratios:
We take a closer look at LLY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 187.69 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 136.25. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 2.18 whereas as Long-Term Debt/Eq ratio is at 1.87.
On August 07, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $715.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 15 ’25 when Montarce Lucas bought 715 shares for $691.79 per share. The transaction valued at 494,627 led to the insider holds 14,685 shares of the business.
Alvarez Ralph bought 758 shares of LLY for $500,473 on Aug 13 ’25. The Director now owns 758 shares after completing the transaction at $660.25 per share. On Aug 13 ’25, another insider, Van Naarden Jacob, who serves as the EVP & Pres., Lilly Oncology of the company, bought 1,000 shares for $647.36 each. As a result, the insider paid 647,360 and bolstered with 20,562 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LLY now has a Market Capitalization of 630397534208 and an Enterprise Value of 663175561216. As of this moment, Lilly(Eli)’s Price-to-Earnings (P/E) ratio for their current fiscal year is 46.63, and their Forward P/E ratio for the next fiscal year is 23.37. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.50 while its Price-to-Book (P/B) ratio in mrq is 36.44. Its current Enterprise Value per Revenue stands at 12.452 whereas that against EBITDA is 26.768.
Stock Price History:
The Beta on a monthly basis for LLY is 0.46, which has changed by -0.26131076 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, LLY has reached a high of $972.53, while it has fallen to a 52-week low of $623.78. The 50-Day Moving Average of the stock is -7.64%, while the 200-Day Moving Average is calculated to be -11.15%.
Shares Statistics:
According to the various share statistics, LLY traded on average about 4.34M shares per day over the past 3-months and 9703000 shares per day over the past 10 days. A total of 946.83M shares are outstanding, with a floating share count of 848.59M. Insiders hold about 10.34% of the company’s shares, while institutions hold 73.60% stake in the company. Shares short for LLY as of 1753920000 were 7172654 with a Short Ratio of 1.65, compared to 1751241600 on 7714191. Therefore, it implies a Short% of Shares Outstanding of 7172654 and a Short% of Float of 0.8999999999999999.
Dividends & Splits
The forward annual dividend rate for LLY is 5.80, which was 5.6 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.008022348The stock’s 5-year Average Dividend Yield is 1.08. The current Payout Ratio is 44.39% for LLY, which recently paid a dividend on 2025-08-15 with an ex-dividend date of 2025-08-15. Stock splits for the company last occurred on 1997-10-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
The dynamic stock of Lilly(Eli) & Co (LLY) is currently being evaluated by a team of 15.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $6.92, with high estimates of $8.54 and low estimates of $6.31.
Analysts are recommending an EPS of between $25.69 and $21.94 for the fiscal current year, implying an average EPS of $22.86. EPS for the following year is $30.19, with 27.0 analysts recommending between $35.82 and $26.2.
Revenue Estimates
According to 16 analysts, the current quarter’s revenue is expected to be $16.09B. It ranges from a high estimate of $16.43B to a low estimate of $15.41B. As of the current estimate, Lilly(Eli) & Co’s year-ago sales were $11.44BFor the next quarter, 16 analysts are estimating revenue of $17.25B. There is a high estimate of $17.66B for the next quarter, whereas the lowest estimate is $16.68B.
A total of 23 analysts have provided revenue estimates for LLY’s current fiscal year. The highest revenue estimate was $64.41B, while the lowest revenue estimate was $60.46B, resulting in an average revenue estimate of $61.76B. In the same quarter a year ago, actual revenue was $45.04BBased on 26 analysts’ estimates, the company’s revenue will be $72.95B in the next fiscal year. The high estimate is $79.16B and the low estimate is $67.01B.
